Authors
Latest:
Are New Medicines Being Developed to Meet the Needs of the Ever-Ageing Population?The elderly population is still underrepresented in clinical trials, with nearly a third of newly registered drugs included an insufficient number of elderly participants, leading to uncertainties regarding safety and effectiveness for prescribers.
Latest:
Are New Medicines Being Developed to Meet the Needs of the Ever-Ageing Population?The elderly population is still underrepresented in clinical trials, with nearly a third of newly registered drugs included an insufficient number of elderly participants, leading to uncertainties regarding safety and effectiveness for prescribers.
Latest:
Patient Registries and Rare DiseasesResearchers are turning to patient registries to fill rare-disease knowledge gaps.
Latest:
Solving the Data Management Challenge in Digital Clinical TrialsRichard Young previously explained on ACT why sponsors need a strong data foundation for successful digital clinical trials. Now he focuses on how to address some of the associated data management challenges.
Latest:
Why You Should Expand Your Patient Advocacy Strategy to Include Health InfluencersWith radio, billboard, TV, and digital advertisements being left in the dust, additional engagement from influencer communities are more likely to be reach patients.
Latest:
Three Steps to Better DecisionsDecision makers can increase collaboration, transparency, efficiency, and effectiveness, while reducing development risks.
Latest:
Train, Analyze, Intervene: How a Three-Pronged Approach Improves Data Quality in Dermatology TrialsThis whitepaper offers readers tips on how to improve the data quality in dermatology trials using a unique, three-pronged approach.
Latest:
How to Get Data and Safety Managers on the Same TeamEvery successful clinical trial must protect patients while collecting complete, accurate data that supports evaluation of the safety and effectiveness of the drug or device. Here’s a closer look at why data and safety managers are so important to a clinical trial, what can go wrong when they aren’t aligned and how to improve collaboration between them.
Latest:
Fair Market Conundrum: Solutions for Sponsors & SitesBreaking through the confusion around fair market value when applying the concept to study budgets.
Latest:
Ethical Review of Decentralized Clinical Trials (DCTs): Tools, Resources & Best PracticesWebinar Date/Time: Wed, Jan 17, 2024 12:00 PM EST
Latest:
Clinical Trials and Social NetworkingThere are significant challenges facing the pharmaceutical and contract research organization (CRO) industries in relation to patient recruitment of clinical trials and the need to implement new strategies to finally overcome what has been called ‘the most difficult and challenging aspect of clinical trials.’
Latest:
MENA: The Dawn of a New EraThe Middle East and North Africa region has seen a recent increase in clinical trials research.
Latest:
IRT: A Competitive Advantage to Accelerate Clinical TrialsInteractive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing.
Latest:
IRT: A Competitive Advantage to Accelerate Clinical TrialsInteractive response technology (IRT) can serve many different functions in clinical research, from patient randomization to making data-driven calculations for patient dosing.
Latest:
3 Ways CTMS Helps Manage Adaptive TrialsWhile adaptive trial designs have been slow to gain traction, there a many benefits to adopting this trial model.
Latest:
Todos Juntos por la SaludA MMG strategic initaitve to address disparities in clinical research participation among Hispanic and Latino communities.
Latest:
Planning Clinical Research Studies for Successful Decentralized TrialsThis podcast will discuss: • How partnering with specialized research organizations can help identify large, diverse patient populations to facilitate clinical studies designed around the patient • How advanced study planning and communication with regulators can ensure more successful execution of decentralized and hybrid clinical trials • The importance of the patient-physician dyad in implementing successful research studies
Latest:
Academic Strength in GermanyThe founding of the KKSN has helped Germany increase its clinical trial output.
Latest:
New Technologies to Improve Clinical Information ManagementToday's pharmaceutical industry faces many challenges as drug development costs continue to climb, pricing pressures mount, and new global markets gain critical importance.
Latest:
Analyzing 2013 Oncology Trends to Predict 2014 DirectionsWhen examining the frequency in use of keywords related to cancer research, some important trends emerge.
Latest:
Moving From Compliance to Competency: A Harmonized Core Competency Framework for the Clinical Research ProfessionalMedicines development and clinical research are among the most heavily regulated activities on a global basis.
Latest:
Playing in the Sandbox--How Local Institutional Review Boards Can Happily Co-Exist with Central IRBsA recent paper published in PLOS ONE addresses research institutions? willingness ?or lack thereof?to defer to central institutional review boards for multicenter clinical trials.
Latest:
Moving From Compliance to Competency: A Harmonized Core Competency Framework for the Clinical Research ProfessionalMedicines development and clinical research are among the most heavily regulated activities on a global basis.
